Method for detecting prostatic cancer

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5303877, 5303879, G01N 3353

Patent

active

058010041

ABSTRACT:
A method for detecting prostatic cancer in patients by detecting the pressure of 5.alpha.-reductase type 2 isozyme in the serum or urine of the patients. The method preferably utilized a biomarker which is the polyclonal antibodies of a peptide representing amino acids 28 to 43 of the 5.alpha.-reductase type 2 isozyme.

REFERENCES:
Silver, RI et al. 1994. J. Urology 152: 433-437.
Thigpen, A E et al. 1993. J. Clin. Invest. 92: 903-10.
Moreno, JG. et al. 1992. Cancer Res. 52:6110-12.
Morminoflan, R. et al. 1992. JBC. 267:19548-19554.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for detecting prostatic cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for detecting prostatic cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting prostatic cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-269050

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.